(Total Views: 258)
Posted On: 01/10/2022 7:45:28 AM
Post# of 3
SHOULD ALLAKOS INC BE ON YOUR INVESTMENT WATCHLIST?
$ALLK
Allakos Inc. (NASDAQ:ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for treatment of inflammatory, and proliferative diseases, faced a setback with disappointing results from a crucial phase 3 trial named Enigma 2 and phase 2/3 Kryptos trial.
Should you invest in the Company or watch from the sidelines?
Read on to find out more!
https://www.aviseanalytics.com/should-allakos...watchlist/
$ALLK
Allakos Inc. (NASDAQ:ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for treatment of inflammatory, and proliferative diseases, faced a setback with disappointing results from a crucial phase 3 trial named Enigma 2 and phase 2/3 Kryptos trial.
Should you invest in the Company or watch from the sidelines?
Read on to find out more!
https://www.aviseanalytics.com/should-allakos...watchlist/
(0)
(0)Scroll down for more posts ▼
